Cardiac Beat Morphology Matching for SVT VT Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable cardioverter defibrillators face challenges in accurately distinguishing between supraventricular tachycardia (SVT) and ventricular tachycardia (VT) due to similar tachycardia cycle lengths, leading to inappropriate therapy delivery and potential delays in life-saving interventions.
Innovation Solution
An apparatus and method for cardiac beat morphology matching using a known template, involving the generation and alignment of a morphology template with an unknown cardiac cycle signal, and computation of a morphology metric such as Normalized Waveform Area Difference (NWAD) to differentiate between SVT and VT.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If rate-based detection is used to detect fast ventricular rate, then tachycardia detection speed is improved, but accuracy in distinguishing SVT from VT deteriorates due to similar tachycardia cycle lengths
Solution Approach 1:
The patent segments the detection process into two distinct phases: (1) rate-based detection for rapid tachycardia identification, and (2) morphology-based discrimination for accurate SVT/VT classification. This segmentation allows the system to benefit from both the speed of rate-based detection and the accuracy of waveform analysis without compromise.
Solution Approach 2:
The patent introduces morphology analysis as an intermediary step between rate-based detection and therapy delivery. This intermediary morphology comparison process acts as a discriminator that resolves the ambiguity created by similar tachycardia cycle lengths, enabling accurate SVT/VT distinction while maintaining rapid detection capabilities.
2Reliability
If high-voltage cardioversion shocks are delivered to terminate tachycardia, then therapy effectiveness is improved, but patient comfort and battery consumption worsen
Solution Approach 1:
The patent implements a feedback mechanism where morphology analysis results continuously inform therapy selection. By comparing unknown waveforms against stored templates and adjusting classification decisions based on morphology match criteria, the system provides feedback that enables more accurate SVT/VT discrimination, thereby reducing inappropriate shock delivery and allowing less aggressive pacing therapies when appropriate.
Solution Approach 2:
The patent performs preliminary morphology analysis and classification before delivering therapy. By pre-establishing waveform templates during normal sinus rhythm and performing morphology comparison in advance of therapy delivery, the system can confidently select less aggressive pacing therapies for SVT, reserving high-voltage shocks only for confirmed VT cases.
3Measurement precision
If morphology waveform matching is performed to distinguish SVT from VT, then classification accuracy is improved, but detection time and computational complexity increase
Solution Approach 1:
The patent applies partial morphology analysis by comparing only critical waveform segments rather than entire cardiac cycles. By focusing the morphology comparison on discriminative features and using configurable match criteria, the system achieves accurate SVT/VT distinction with reduced computational burden and faster processing time.
Solution Approach 2:
The patent performs preliminary template establishment during normal sinus rhythm periods before tachycardia detection is needed. By pre-processing and storing representative waveform templates, the system eliminates the need for complex real-time template generation during tachycardia events, significantly reducing detection time while maintaining classification accuracy.
4Object-affected harmful factors
If less aggressive pacing therapies are used to terminate tachycardia, then patient comfort and battery conservation are improved, but therapy success rate deteriorates
Solution Approach 1:
The patent uses morphology analysis feedback to dynamically adjust therapy selection. By continuously comparing waveform morphology against stored templates and updating classification confidence, the system provides feedback that enables high success rates for pacing therapy in confirmed SVT cases while maintaining the option to escalate to more aggressive therapies if morphology classification is uncertain or therapy fails.
Solution Approach 2:
The patent performs preliminary morphology-based classification to identify SVT with high confidence before initiating less aggressive pacing therapies. By establishing waveform templates and performing morphology comparison in advance, the system can confidently select pacing therapies for SVT, knowing that high success rates are achievable when classification accuracy is high.
Data Source
AI summary
A medical device and associated method for classifying an unknown cardiac signal operate to sense a cardiac signal over known cardiac cycles and generate a template of the known cardiac cycles. An unknown cardiac signal is sensed over an unknown cardiac cycle. A template alignment point and an unknown cardiac signal alignment point are identified by using a fourth order difference signal. The template and the unknown cardiac signal are aligned across an alignment window by aligning the template alignment point and the unknown cardiac signal alignment point. A morphology match metric measuring a similarity between the aligned template and the unknown cardiac signal is computed.